Clinical Trials Directory

Trials / Completed

CompletedNCT02741622

Brain Derived Neurotropic Factor Response to Aerobic Exercise Intensity in Depressive Patients.

Effects of Aerobic Exercise Intensity on Affective States and Brain Derived Neurotropic Factor in Patients With Depression

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
St. Olavs Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Acute aerobic exercise improves affective stats in patients with mental illnesses. Brain derived neurotropic factor (BDNF) may be a biological mechanism that contributes to the affective benefits. The magnitude of the increase of serum BDNF might be exercise intensity dependent, but no study has compared low high-aerobic-intensity training at 90-95 % of the maximal heart rate (HRmax) with long-slow-distance training at 70 % of the HRmax in patients with depression. The aim of this study is to compare changes in serum BDNF levels after high-aerobic-intensity training and long-slow-distance training in a intra-individual design in patients suffering from depression. The results will give indications of a possible difference in BDNF response between aerobic intensities and may be uses as pilot data for calculating sample size.

Conditions

Interventions

TypeNameDescription
BEHAVIORALHigh aerobic intensity training (HIT)One training session, high aerobic intensity training (HIT) at 90-95 % of the maximal heart rate (HRmax)
BEHAVIORALLong slow distance training (LSD)One training session, long slow distance training (LSD) at 70 % of the HRmax

Timeline

Start date
2016-03-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2016-04-18
Last updated
2018-12-04

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT02741622. Inclusion in this directory is not an endorsement.